-+ 0.00%
-+ 0.00%
-+ 0.00%

Pfizer Reports TUKYSA Combo Extends Progression-Free Survival in HER2+ Metastatic Breast Cancer

Reuters·12/10/2025 13:15:21

Please log in to view news